Home > Boards > US Listed > Biotechs > Neuronetics Inc. (STIM)

Thank you I'll take a look. Yes it

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
urge2surge Member Profile
 
Followed By 17
Posts 1,863
Boards Moderated 0
Alias Born 11/09/19
160x600 placeholder
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting GlobeNewswire Inc. - 6/9/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2021 6:27:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 7:16:22 PM
Neuronetics to Present at The JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/3/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:30:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:29:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:28:16 PM
Neuronetics Names Todd Cushman as Vice President, Business Development GlobeNewswire Inc. - 6/1/2021 8:00:00 AM
Neuronetics to Present at the William Blair 41st Annual Growth Stock Conference GlobeNewswire Inc. - 5/20/2021 8:00:00 AM
Neuronetics marks 100K NeuroStar treatments at Southern California TMS Center Seeking Alpha - 5/17/2021 9:08:45 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/4/2021 4:35:49 PM
ARNC, BLRX, BLDP and MAXR among midday movers Seeking Alpha - 5/4/2021 12:40:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 7:38:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 7:31:30 AM
Neuronetics EPS beats by $0.01, beats on revenue Seeking Alpha - 5/4/2021 7:23:28 AM
Neuronetics Reports First Quarter 2021 Financial and Operating Results GlobeNewswire Inc. - 5/4/2021 7:00:00 AM
Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences GlobeNewswire Inc. - 5/3/2021 8:00:00 AM
Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual Meeting GlobeNewswire Inc. - 4/29/2021 8:00:00 AM
Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call GlobeNewswire Inc. - 4/20/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/14/2021 5:20:41 PM
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors GlobeNewswire Inc. - 4/14/2021 5:15:14 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/14/2021 4:10:47 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/14/2021 4:07:33 PM
urge2surge   Saturday, 02/06/21 02:05:27 PM
Re: EarthBard post# 18
Post # of 19 
Thank you I'll take a look. Yes it works. If they announce trials on Alzheimer's, who knows where this goes. As it is this is a solid growth company. I was surprised at the secondary offering in light of their revenues.
As for BWAY, the only negative off the cuff is that it is an Israeli company. Tend to be big sink holes...

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences